Ionis Pharmaceuticals | 4:持股变动声明-董事 Hayden Michael R
Ionis Pharmaceuticals | 8-K:重大事件
Ionis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BB Biotech AG(5.0%),Biotech Invest N.V.(5.0%)
Ionis Pharmaceuticals | 4:持股变动声明-高管 Swayze Eric
Ionis Pharmaceuticals | 4:持股变动声明-高管 Monia Brett P
Ionis Pharmaceuticals | 4:持股变动声明-董事 LOSCALZO JOSEPH
Ionis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-T. Rowe Price Investment Management, Inc.(9.0%)
Ionis Pharmaceuticals | 144/A:其他
Ionis Pharmaceuticals | 144:拟议出售证券
Ionis Pharmaceuticals | 144:拟议出售证券
Ionis Pharmaceuticals | 144:拟议出售证券
Ionis Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Wellington Management Group LLP(5.76%),Wellington Group Holdings LLP(5.76%)等
Ionis Pharmaceuticals | 10-Q:2024财年三季报
Ionis Pharmaceuticals | 8-K:爱奥尼斯公布2024年第三季度财务业绩
Ionis Pharmaceuticals | 4:持股变动声明-高管 Swayze Eric
Ionis Pharmaceuticals | 4:持股变动声明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 4:持股变动声明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 3:首次持股声明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 8-K:重大事件
Ionis Pharmaceuticals | 424B5:募资说明书
暂无数据